Gallbladder Cancer Therapeutics - Pipeline Assessment

and Market Forecasts to 2018

On 16thDecember 2014

Summary
The industry analysis specialist, has released its new report, Gallbladder Cancer Therapeutics Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of
information and analysis on the global Gallbladder Cancer Therapeutics market. The report
identifies the key trends shaping and driving the global Gallbladder Cancer Therapeutics
market. The report also provides insights on the prevalent competitive landscape and the
emerging players expected to significantly alter the market positioning of the current market
leaders. Most importantly, the report provides valuable insights on the pipeline products within
the global Gallbladder Cancer Therapeutics sector. This report is built using data and
information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-gallbladder-cancer-therapeutics-pipeline-assessment-and-marketforecasts-135233

Scope
The report provides information on the key drivers and challenges of the Gallbladder Cancer
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Gallbladder
Cancer Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Gallbladder Cancer
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Gallbladder Cancer Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Gallbladder Cancer
Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Gallbladder Cancer Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Gallbladder Cancer Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Gallbladder Cancer Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Gallbladder Cancer Therapeutics - Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.4 Pathophysiology
2.5 Signs and Symptoms
2.6 Diagnosis
2.6.1 Physical exam and history
2.6.2 Ultrasound exam
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.6.3 Liver function tests

2.6.4 Carcinoembryonic antigen (CEA) assay
2.6.5 Cancer antigen 19-9 (CA 19-9) assay
2.6.6 CT scan (CAT scan)
2.6.7 Blood chemistry studies
2.6.8 Chest x-ray
2.6.9 MRI (magnetic resonance imaging)
2.6.10 ERCP (Endoscopic Retrograde Cholangiopancreatography)
2.6.11 Biopsy
2.6.12 Laparoscopy
2.6.13 PTC (Percutaneous Transhepatic Cholangiography)
2.7 Staging
2.7.1 TNM Classification
2.7.2 Treatment Options Based on the Extent of Cancer
2.8 Treatment
2.8.1 Surgery
2.8.2 Chemotherapy
2.8.3 Radiation therapy (RT)
2.9 Chemotherapy Regimens
2.10 GlobalData Pipeline Report Guidance
3 Gallbladder Cancer Therapeutics - Market Characterization
3.1 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Global
3.2 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Global
3.3 Gallbladder Cancer Therapeutics Market Size (2005-2010) - US
3.4 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - The US
3.5 Gallbladder Cancer Therapeutics Market Size (2005-2010) - The UK
3.6 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - The UK
3.7 Gallbladder Cancer Therapeutics Market Size (2005-2010) - France
3.8 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - France
3.9 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Germany
3.10 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Germany
3.11 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Italy
3.12 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Italy
3.13 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Spain
3.14 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Spain
3.15 Gallbladder Cancer Therapeutics Market Size (2005-2010) - Japan
3.16 Gallbladder Cancer Therapeutics Market Forecast (2010-2018) - Japan
3.17 Drivers and Barriers for the Gallbladder Cancer Therapeutics Market
3.17.1 Drivers for the Gallbladder Cancer Therapeutics Market
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

3.17.2 Barriers for the Gallbladder Cancer Therapeutics Market

3.18 Key Events Impacting the Future Market
3.18.1 Opportunity and Unmet Need
3.19 Key Takeaway
4 Gallbladder Cancer Therapeutics Market - Competitive Assessment
4.1 Overview
4.1.1 Strategic Competitor Assessment
4.2 Profiles of the Commonly Used Products in the Gallbladder Cancer Therapeutics Market
4.2.1 Gemcitabine
4.2.2 Gemcitabine and Cisplatin
4.2.3 Gemcitabine and Oxaliplatin (GEMOX)
4.2.4 Gemcitabine and Capecitabine
4.2.5 5-Fluorouracil (5-FU) and Cisplatin
4.3 Key Takeaway
5 Gallbladder Cancer Therapeutics Market - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Gallbladder Cancer Pipeline Analysis - Pipeline by Clinical Phases of Development
5.3.1 Gallbladder Cancer Therapeutics - Phase II Pipeline
5.3.2 Gallbladder Cancer Therapeutics - Phase I/II Pipeline
5.3.3 Gallbladder Cancer Therapeutics - Phase I Pipeline
5.4 Gallbladder Cancer Pipeline by Mechanism of Action
5.5 Gallbladder Cancer Technology Trends Analytical Framework
5.6 Profiles of Phase II Drugs under Clinical Development
5.6.1 Caprelsa (vandetanib)
5.6.2 Sinofuan (fluorouracil implant)
5.7 Key Takeaway
6 Gallbladder Cancer Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Country (US, EU5 and Japan)
6.2 Clinical Trials Mapping by Phase
6.3 Clinical Trials Mapping by Trial Status
6.4 Overall Sponsors
6.5 Prominent Sponsors
6.6 Top Companies Participating in Gallbladder Cancer Therapeutics Clinical Trials
7 Gallbladder Cancer Therapeutics - Strategic Assessment
7.1 Future Market Competition Scenario
8 Gallbladder Cancer Therapeutics - Future Players in The Market
8.1 Introduction
8.2 Company Profiles
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

8.2.1 AstraZeneca PLC

8.2.2 Simcere Pharmaceutical Co. Ltd.
9 Gallbladder Cancer Therapeutics- Appendix
9.1 Definitions
9.2 Acronyms
9.3 Research Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Forecasting
9.3.4 Primary Research
9.3.5 Expert Panel Validation
9.4 Contact Us
9.5 Disclaimer
9.6 Bibliography

List Of Tables
Table 1: Survival Rates of Gallbladder Cancer in Various Stages
Table 2: Prevalence of Gallbladder Cancer in Major Markets
Table 3: Gallbladder Cancer, TNM Definitions
Table 4: Gallbladder Cancer, Stage Grouping
Table 5: Treatment Options Based on the Extent of Cancer
Table 6: Gallbladder Cancer Chemotherapy regimens
Table 7: Gallbladder Cancer Therapeutics Market, Global, Revenue ($m), 2005-2010
Table 8: Gallbladder Cancer Therapeutics Market, Global, Forecast ($m), 2010-2018
Table 9: Gallbladder Cancer Therapeutics Market, The US, Revenue ($m), 2005-2010
Table 10: Gallbladder Cancer Therapeutics Market, The US, Revenue ($m), 2010-2018
Table 11: Gallbladder Cancer Therapeutics Market, The UK, Revenue ($m), 2005-2010
Table 12: Gallbladder Cancer Therapeutics Market, The UK, Forecast ($m), 2010-2018
Table 13: Gallbladder Cancer Therapeutics Market, France, Revenue ($m), 2005-2010
Table 14: Gallbladder Cancer Therapeutics Market, France, Forecast ($m), 2010-2018
Table 15: Gallbladder Cancer Therapeutics Market, Germany, Revenue ($m), 2005-2010
Table 16: Gallbladder Cancer Therapeutics Market, Germany, Forecast ($m), 2010-2018
Table 17: Gallbladder Cancer Therapeutics Market, Italy, Revenue ($m), 2005-2010
Table 18: Gallbladder Cancer Therapeutics Market, Italy, Forecast ($m), 2010-2018
Table 19: Gallbladder Cancer Therapeutics Market, Spain, Revenue ($m), 2005-2010
Table 20: Gallbladder Cancer Therapeutics Market, Spain, Forecast ($m), 2010-2018
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 21: Gallbladder Cancer Therapeutics Market, Japan, Revenue ($m), 2005-2010
Table 22: Gallbladder Cancer Therapeutics Market, Japan, Forecast ($m), 2010-2018
Table 23: Gallbladder Cancer - Phase II Pipeline
Table 24: Gallbladder Cancer Therapeutics - Phase I/II Pipeline
Table 25: Gallbladder Cancer Therapeutics - Phase I Pipeline
Table 26: Gallbladder Cancer Therapeutics - Clinical Trials by Country, 2011
Table 27: Gallbladder Cancer Therapeutics - Clinical Trials by Phase, 2011
Table 28: Gallbladder Cancer Therapeutics - Clinical Trials by Status, 2011
Table 29: Gallbladder Cancer Therapeutics - Clinical Trials, by Overall Sponsors, 2011
Table 30: Gallbladder Cancer Therapeutics - Clinical Trials by Prominent Sponsors, 2011
Table 31: Gallbladder Cancer Therapeutics Clinical Trial - Company Sponsors by Phase, 2011
Table 32: AstraZeneca - Gallbladder Cancer Pipeline
Table 33: Simcere Pharmaceutical - Gallbladder Cancer Pipeline

List Of Figures
Figure 1: Anatomy of the Gallbladder
Figure 2: Magnetic Resonance Imaging
Figure 3: Gallbladder Cancer Therapeutics Market, Global, Revenue ($m), 2005-2010
Figure 4: Gallbladder Cancer Therapeutics, Market Share ($m), 2010
Figure 5: Gallbladder Cancer Therapeutics Market, Global, Forecast ($m), 2010-2018
Figure 6: Gallbladder Cancer Therapeutics, Market Share ($m), 2018
Figure 7: Gallbladder Cancer Therapeutics Market, The US, Revenue ($m), 2005-2010
Figure 8: Gallbladder Cancer Therapeutics Market, The US, Forecast ($m), 2010-2018
Figure 9: Gallbladder Cancer Therapeutics Market, The UK, Revenue ($m), 2005-2010
Figure 10: Gallbladder Cancer Therapeutics, The UK, Forecast ($m), 2010-2018
Figure 11: Gallbladder Cancer Therapeutics Market, France, Revenue ($m), 2005-2010
Figure 12: Gallbladder Cancer Therapeutics Market, France, Forecast ($m), 2010-2018
Figure 13: Gallbladder Cancer Therapeutics Market, Germany, Revenue ($m), 2005-2010
Figure 14: Gallbladder Cancer Therapeutics Market, Germany, Forecast ($m), 2010-2018
Figure 15: Gallbladder Cancer Therapeutics Market, Italy, Revenue ($m), 2005-2010
Figure 16: Gallbladder Cancer Therapeutics Market, Italy, Forecast ($m), 2010-2018
Figure 17: Gallbladder Cancer Therapeutics Market, Spain, Revenue ($m), 2005-2010
Figure 18: Gallbladder Cancer Therapeutics Market, Spain, Forecast ($m), 2010-2018
Figure 19: Gallbladder Cancer Therapeutics Market, Japan, Revenue ($m), 2005-2010
Figure 20: Gallbladder Cancer Therapeutics Market, Japan, Forecast ($m), 2010-2018
Figure 21: Gallbladder Cancer Therapeutics, Key Events Impacting the Future Market
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 22: Opportunity and Unmet Need in the Gallbladder Cancer Therapeutics Market, 2011
Figure 23: Gallbladder Cancer Therapeutics Market- Strategic Competitor Assessment, 2011
Figure 24: Gallbladder Cancer Therapeutics - Pipeline by Phase of Clinical Development, 2011
Figure 25: Gallbladder Cancer Therapeutics - Clinical Pipeline by Mechanism Of Action, 2011
Figure 26: Gallbladder Cancer Therapeutics - Technology Trends Analytical Framework, 2011
Figure 27: Gallbladder Cancer Therapeutics - Technology Trends Analytical Framework Description, 2011
Figure 28: Gallbladder Cancer Therapeutics - Clinical Trials by Country, 2011
Figure 29: Gallbladder Cancer Therapeutics - Clinical Trials by Phase, 2011
Figure 30: Gallbladder Cancer Therapeutics - Clinical Trials by Status, 2011
Figure 31: Gallbladder Cancer Therapeutics - Clinical Trials by Overall Sponsors, 2011
Figure 32: Gallbladder Cancer Therapeutics - Clinical trials by Prominent Sponsors, 2011
Figure 33: Gallbladder Cancer Therapeutics Clinical Trial - Company Sponsors by Phase, 2011
Figure 34: Gallbladder Cancer Therapeutics, Strategic Assessment, 2011
Figure 35: Gallbladder Cancer Therapeutics Market - Clinical Pipeline by Company , 2011
Figure 36: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Related Reports:
Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

To know more on Gallbladder Cancer Therapeutics - Pipeline Assessment and

Market Forecasts to 2018
http://www.jsbmarketresearch.com/healthcare-medical/r-gallbladder-cancertherapeutics-pipeline-assessment-and-market-forecasts-135233

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/